REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

September 30, 2027

Conditions

Primary Aldosteronism

Interventions

OTHER

Renin measurements

Use of plasma renin measurements to guide MRA dosing, aiming for plasma renin unsuppression

Trial Locations (1)

RECRUITING

Hôpital du Sacré-Coeur de Montréal, Montreal

All Listed Sponsors

lead

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER